Atlas Trials

A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3

Clinical trial NCT00002123 · COMPLETED

Trial details

NCT number
NCT00002123
Sponsor
Pharmacia and Upjohn
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HIV Infections

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.